Department of Pediatrics, University of Naples "Federico II", Italy.
Inflamm Bowel Dis. 2013 Jul;19(8):1617-21. doi: 10.1097/MIB.0b013e318281f469.
An involvement of the appendiceal orifice as a distintive skip lesion in adults with left side ulcerative colitis (UC) has been reported. The aim of our prospective study was to evaluate, by endoscopy and histology, the prevalence of periappendiceal inflammation (PAI) in children affected by UC.
Fifty of 77 consecutive children undergoing total colonoscopy, who had a diagnosis of UC not extended beyond the hepatic flexure were enrolled.
PAI was endoscopically present in 16 of 50 patients (32%) with UC. Patients were divided in 2 groups: group A included the 16 patients with PAI, whereas group B included 34 patients without PAI. We found that among the 2 groups, PAI was more frequent in patients with new diagnosis than in those with pre-existing UC (P = 0.016). At index colonoscopy, the patients of group A had a significant major extent of disease (P = 0.013). Moreover, the histologic grade of inflammation at the ascending colon was significantly higher in group A than in group B (P = 0.014). Clinical activity, measured by pediatric ulcerative colitis activity index, and use of medication did not show significant differences among groups (P = 0.464 and P = 0.723, respectively). The use of immunosuppressant was significantly higher in group A than in group B.
PAI is a frequent skip lesion in children with UC. It seems more frequent in patients with new diagnosis, and it is associated with a major extent of the disease and with a higher grade of histologic inflammation at the ascending colon.
已有报道称,成人左侧溃疡性结肠炎(UC)患者阑尾口作为独特的跳跃性病变存在。本前瞻性研究的目的是通过内镜和组织学评估患有 UC 的儿童的阑尾周围炎症(PAI)的患病率。
77 例连续接受全结肠镜检查且 UC 未超过肝曲的患儿中,有 50 例入组。
50 例 UC 患儿中有 16 例(32%)内镜下存在 PAI。患儿分为 2 组:A 组包括 16 例有 PAI 的患儿,B 组包括 34 例无 PAI 的患儿。我们发现,在这 2 组中,新发 UC 患儿中 PAI 更为常见(P = 0.016)。在首次结肠镜检查时,A 组患者的疾病主要程度明显更严重(P = 0.013)。此外,A 组患者的升结肠组织学炎症分级明显高于 B 组(P = 0.014)。A 组和 B 组之间的临床活动(通过小儿溃疡性结肠炎活动指数测量)和用药情况无显著差异(P = 0.464 和 P = 0.723)。A 组的免疫抑制剂使用率明显高于 B 组。
PAI 是 UC 患儿常见的跳跃性病变。在新发 UC 患儿中似乎更为常见,与疾病主要程度和升结肠组织学炎症分级较高有关。